Harry Lesmana
Impact in
-
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Sphingolipid Metabolism and Signaling 2
-
- Blood groups and transfusion 3
- Acute Myeloid Leukemia Research 3
- Co-authors
- Kim E. Nichols (5 shared papers)Marcin W. Włodarski (3 shared papers)Robert J. Hopkin (4 shared papers)Seyed Ali Hosseini (1 shared paper)Barbara Hallinan (1 shared paper)Mark B. Schapiro (1 shared paper)Kevin E. Bove (1 shared paper)Navneet S. Majhail (1 shared paper)
- Journals
- Blood (6 papers)Clinical Cancer Research (3 papers)Pediatric Blood & Cancer (2 papers)Genetics in Medicine (1 paper)Clinical Epigenetics (1 paper)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Harry Lesmana
21 papers receiving 117 citations
Peers
Comparison fields: 5 of 37
- Hematology 28
- Genetics 15
- Genetics 22
- Oncology 17
- Cancer Research 9
Countries citing papers authored by Harry Lesmana
This map shows the geographic impact of Harry Lesmana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Lesmana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Lesmana more than expected).
Fields of papers citing papers by Harry Lesmana
This network shows the impact of papers produced by Harry Lesmana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Lesmana. The network helps show where Harry Lesmana may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Lesmana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 17 | |
| 2 | 2019 | 14 | |
| 3 | 2018 | 14 | |
| 4 | 2020 | 10 | |
| 5 | 2021 | 9 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 7 | |
| 8 | 2020 | 7 | |
| 9 | 2017 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2024 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2020 | 1 |
About Harry Lesmana
Harry Lesmana is a scholar working on Molecular Biology, Hematology, Genetics, Genetics and Physiology, having authored 23 papers that have together received 119 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (5 papers), Blood disorders and treatments (4 papers), Blood groups and transfusion (3 papers), Acute Myeloid Leukemia Research (3 papers), Sphingolipid Metabolism and Signaling (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (28 citations), Genetics (15 citations), Genetics (22 citations), Oncology (17 citations) and Cancer Research (9 citations). Harry Lesmana has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Kim E. Nichols, Marcin W. Włodarski, Robert J. Hopkin, Seyed Ali Hosseini, Barbara Hallinan, Mark B. Schapiro, Kevin E. Bove, Navneet S. Majhail, T. Burrow and Sara Lewis. Their work appears in journals such as Blood, Clinical Cancer Research, Pediatric Blood & Cancer, Genetics in Medicine and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.